(MedPage Today) — Two analyses suggested that non-medical (illicit) gabapentin use persisted in recent years as patterns in prescribing shifted.
The first analysis, led by Sara Karami, PhD, MPH, of the FDA’s Center for Drug Evaluation and Research…
Source link : https://www.medpagetoday.com/neurology/painmanagement/119776
Author :
Publish date : 2026-02-06 19:26:00
Copyright for syndicated content belongs to the linked Source.
